Clinical trial Recruiting at 2 sites Observational Ages 21 to 85

Monitoring blood pressure continuously to improve hypertension management

Official title: OBPM_FORESEE2024: Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk in a Multi-ethnic European Population: an Observational Cohorts' Study

Run by Aktiia SA · NCT06670677 · Data updated 2026-11-12

This study is testing whether using a continuous blood pressure monitoring device can help people with high blood pressure manage their condition better over ten years.

Quick facts

Study typeObservational
Ages21 Years to 85 Years
SexAll
Enrollment15000 (estimated)
SponsorAktiia SA
Industry-sponsored
Locations2 sites (Lausanne and 1 other locations)
StatusRecruiting
StartedMay 12, 2025
Main results expectedMay 31, 2035
Study endsMay 31, 2035
Registry record updatedMay 14, 2025
Trial IDNCT06670677 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 to 85 who are existing users of the Aktiia G1 device and reside in Switzerland, Germany, or the UK.

Probably not a fit

Patients with certain cardiac arrhythmias, severe peripheral perfusion issues, or other specified health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical benefits of the Aktiia blood pressure monitoring device, focusing on its ability to provide continuous blood pressure readings and correlate these with various health and environmental factors. Participants, who are existing users of the Aktiia G1 device, will wear the device continuously for 10 years and complete online surveys every six months about their lifestyle and health. The study aims to gather extensive data to enhance hypertension management and predict cardiovascular risks based on continuous monitoring. The research includes two arms based on the smartphone operating system used by participants.

Why it matters

Potential benefit: If successful, this study could lead to improved management of hypertension and reduced cardiovascular risk for patients.

How similar studies have gone: While this approach is innovative in its use of continuous monitoring technology, similar studies have shown promise in managing hypertension through regular monitoring.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult subjects aged 21 to 85 years old
2. Subjects living in Switzerland, Germany or in the UK
3. Subjects that are:

   Aktiia users owning a smartphone with either iOS or Android operating system (ARMs 1 and 2); or Aktiia non-users owning a smartphone with iOS or Android operating system (ARM 3)
4. Subjects agreeing to follow the study procedures.

Exclusion Criteria:

1. Subjects suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including resting tachycardia (heart rate at rest \> 120bpm) and atrial fibrillation;
2. Subjects suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL / min / 1.73 m2), untreated hyper-/ hypothyroidism, pheochromocytoma, or arteriovenous fistula;
3. Subjects suffering from polyneuropathy;
4. on pregnant women;
5. Subjects with damaged / injured skin at the wrists (for bracelet measurements) or at index fingers (for camera measurements)
6. Subjects with amputated index fingers (for camera measurements) or amputated upper limb;
7. Subjects below 21 years old and above 85 years old.

Where it's running

  • Fully remote study- no physical investigational site
    Lausanne, Switzerland
    Recruiting
  • Fully remote study- no physical investigational site
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.